humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 7, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 7, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 17, Status: Au…EMA What Is NewHuman medicines European public assessment report (EPAR): Febuxostat Viatris (previously Febuxostat Mylan), febuxostat, Date of authorisation: 15/06/2017, Revision: 17, Status: Au…EMA What Is NewHuman medicines European public assessment report (EPAR): Diacomit, stiripentol, Date of authorisation: 03/01/2007, Date of refusal: 11/02/2009, Revision: 21, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Diacomit, stiripentol, Date of authorisation: 03/01/2007, Date of refusal: 11/02/2009, Revision: 21, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Beromun, tasonermin, Date of authorisation: 12/04/1999, Revision: 16, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Beromun, tasonermin, Date of authorisation: 12/04/1999, Revision: 16, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Iressa, gefitinib, Date of authorisation: 24/06/2009, Revision: 16, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Iressa, gefitinib, Date of authorisation: 24/06/2009, Revision: 16, Status: Authorised2 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources